BioCentury
ARTICLE | Clinical News

Adlea capsaicin: Phase II started

October 8, 2007 7:00 AM UTC

ANSV began a double-blind, placebo-controlled Phase II trial in 160 total hip arthroplasty patients of a single 15 mg dose of Adlea instilled into the surgical wound prior to closure. ...